Citations

Mayo Clinic

Clear

12581 citation(s) found for "Um, John".

Nephron Sparing Surgery for Appropriately Selected Renal Cell Carcinoma Between 4 and 7 Cm Results in Outcome Similar to Radical Nephrectomy
Leibovich, Bradley C. , Blute, Michael L., Cheville, John C. , Lohse, Christine M. , Weaver, Amy L. , Zincke, Horst

Journal of Urology | August 25, 2004 | Volume: 171 | Issue: 3 | Pages: 1066-1070

10.1097/01.ju.0000113274.40885.db | PMID 14767272 Get It

Expression of Insulin-like Growth Factor I Receptor and Survival in Patients with Clear Cell Renal Cell Carcinoma
Parker, Alexander S. , Cheville, John C. , Lohse, Christine M. , Cerhan, James R. , Blute, Michael L., Cerhan, James R

Journal of Urology | August 25, 2004 | Volume: 170 | Issue: 2 | Pages: 420-424

10.1097/01.ju.0000071474.70103.92 | PMID 12853790 Get It

Whole Urinary Proteins Coat Calcium Oxalate Monohydrate Crystals to Greatly Decrease Their Adhesion to Renal Cells
Farell, Gerard, Kumar, Vivek , Lieske, John C.

Journal of Urology | August 25, 2004 | Volume: 170 | Issue: 1 | Pages: 221-225

10.1097/01.ju.0000059540.36463.9f | PMID 12796693 Get It

Transvaginal Tape Lysis for Urinary Obstruction After Tension-Free Vaginal Tape Placement
Croak, Andrew J., Schulte, Valerie, Peron, Salvador E., Klingele, Christopher J., Gebhart, John B. , Lee, Raymond

Journal of Urology | August 25, 2004 | Volume: 169 | Issue: 6 | Pages: 2238-2241

10.1097/01.ju.0000063781.01787.10 | PMID 12771758 Get It

Use of a Temporary Ureteral Drainage Stent After Uncomplicated Ureteroscopy: Results From a Phase II Clinical Trial
Lingeman, James E., Preminger, Glenn M. , Berger, Yitzhak , Denstedt, John D. , Goldstone, Lawrence, Segura, Joseph W., Auge, Brian K., Watterson, James, Kuo, Ramsay L.

Journal of Urology | August 25, 2004 | Volume: 169 | Issue: 5 | Pages: 1682-1688

10.1097/01.ju.0000055600.18515.a1 | PMID 12686808 Get It

The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical Prostatectomy
Ward, John F. , Blute, Michael L., Slezak, Jeffrey M., Bergstralh, Erik J., Zincke, Horst

Journal of Urology | August 25, 2004 | Volume: 170 | Issue: 5 | Pages: 1872-1876

10.1097/01.ju.0000091876.13656.2e | PMID 14532796 Get It

The Effect of Bilaterality, Pathological Features And Surgical Outcome in Nonhereditary Renal Cell Carcinoma
Blute, Michael L., Itano, Nancy B., Cheville, John C. , Weaver, Amy L. , Lohse, Christine M. , Zincke, Horst

Journal of Urology | August 25, 2004 | Volume: 169 | Issue: 4 | Pages: 1276-1281

10.1097/01.ju.0000051883.41237.43 | PMID 12629342 Get It

Charlson Co-Morbidity Index as a Predictor of Outcome After Surgery for Renal Cell Carcinoma With Renal Vein, Vena Cava or Right Atrium Extension.
Gettman, Matthew T., BOELTER, CHRISTOPHER W., Cheville, John C. , Zincke, Horst, Bryant, Sandra C. , Blute, Michael L., Boelter, Christopher

Journal of Urology | August 25, 2004 | Volume: 169 | Issue: 4 | Pages: 1282-1286

10.1097/01.ju.0000049093.03392.cc | PMID 12629343 Get It

Solid Renal Tumors: An Analysis of Pathological Features Related to Tumor Size
Frank, Igor, Blute, Michael L., Cheville, John C. , Lohse, Christine M. , Weaver, Amy L. , Zincke, Horst

Journal of Urology | August 25, 2004 | Volume: 170 | Issue: 6 | Pages: 2217-2220

10.1097/01.ju.0000095475.12515.5e | PMID 14634382 Get It

Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice
Flynn, Jeffrey C. , Gardas, A, Wan, Qiang , Góra, Monika , Alsharabi, Ghazwan, Wei, Wenjing , David, Chella S., Kong, Yi‐chi M., Banga, J. Paul, Giraldo, Alvaro A.

Clinical and Experimental Immunology | August 20, 2004 | Volume: 137 | Issue: 3 | Pages: 503-512

10.1111/j.1365-2249.2004.02553.x | PMID 15320899 Get It

SUMMARYMurine experimental autoimmune thyroiditis (EAT), characterized by thyroid destruction after immunization with thyroglobulin (Tg), has long been a useful model of organ-specific autoimmune disease. More recently, porcine thyroid peroxidase (pTPO) has also been shown to induce thyroiditis, but these results have not been confirmed. When (C57BL/6 × CBA)F1 mice, recently shown to be susceptible to mouse TPO-induced EAT, were immunized with plasmid DNA to human TPO (hTPO) and cytokines IL-12 or GM-CSF, significant antibody (Ab) titres were generated, but minimal thyroiditis was detected in one mouse only from the TPO + GM-CSF immunized group. However, after TPO DNA immunization of HLA-DR3 transgenic class II-deficient NOD mice, thyroiditis was present in 23% of mice injected with TPO + IL-12 or GM-CSF. We also used another marker for assessing the closeness of the model to human thyroid autoimmunity by examining the epitope profile of the anti-TPO Abs to immunodominant determinants on TPO. Remarkably, the majority of the anti-TPO Abs was directed to immunodominant regions A and B, demonstrating the close replication of the model to human autoimmunity. TPO protein immunizations of HLA-DR3 transgenic mice with recombinant hTPO did not result in thyroiditis, nor did immunization of other mice expressing HLA class II transgenes HLA-DR4 or HLA-DQ8, with differential susceptibility to Tg-induced EAT. Moreover, our efforts to duplicate exactly the experimental procedures used with pTPO also failed to induce thyroiditis. The success of hTPO plasmid DNA immunization of DR3+ mice, similar to our reports on Tg-induced thyroiditis and thyrotropin receptor DNA-induced Graves’ hyperthyroidism, underscores the importance of DR3 genes for all three major thyroid antigens, and provides another humanized model to study autoimmune thyroid disease.